Pimobendan is one of the most commonly prescribed heart medications for dogs, used to help hearts that aren’t pumping as well as they should. But exactly how it works inside an awake, living dog’s heart has been hard to measure precisely — until now. A new pilot study published in Frontiers in Veterinary Science used detailed heart scans in awake Beagles and found that pimobendan measurably raised stroke volume and key heart-squeeze measurements for several hours after a single dose.
This small but carefully designed study adds concrete detail to our picture of how pimobendan does its job. While the findings come from just five healthy dogs and can’t be applied directly to every dog with heart disease, they offer vets a clearer set of tools for tracking whether the drug is working.
What Pimobendan Does — and Why Researchers Wanted a Closer Look
Pimobendan is used mainly in dogs with enlarged hearts or heart failure, conditions like dilated cardiomyopathy (a weak, floppy heart) or mitral valve disease (where the heart’s inner valve leaks). The drug helps the heart squeeze harder and also relaxes the blood vessels, reducing the workload.
Vets have used pimobendan for years, but the precise way it changes the heart’s mechanics in a real, awake dog hadn’t been fully mapped out. Most earlier work relied on anesthetized animals, which can change how the heart behaves. This study was designed to get a cleaner, more real-world picture by working with conscious dogs.
How the Study Was Conducted
Researchers gave a single intravenous (IV — directly into the vein) dose of pimobendan to five healthy adult male Beagles. Before and after the dose, they used a technique called echocardiography — essentially an ultrasound of the heart — to track what was happening inside the chest.
A key part of the echocardiography was something called myocardial strain imaging. Think of this as measuring how much the heart muscle stretches and squeezes with each beat. Standard heart scans tell you how much blood is pumped out; strain imaging goes further and shows you how the muscle itself is moving to do that pumping. It’s a bit like the difference between measuring how much water comes out of a hose versus watching the rubber walls of the hose flex.
Repeated scans were taken over several hours so researchers could track exactly how the drug’s effects changed over time.
What the Scans Revealed
Stroke Volume and Squeeze Measures Both Rose
The central finding was that pimobendan caused a clear, measurable increase in stroke volume — the amount of blood the heart pushes out with each beat — and this increase lasted for hours after the dose. At the same time, several myocardial strain measurements (the heart-squeeze numbers) also improved.
In plain terms: the drug made the hearts pump more blood per beat, and the heart muscle was working more vigorously to do it. This confirmed in awake dogs what earlier research had hinted at.
One Measurement Tracked the Pump Boost Most Closely
The second key finding was that one specific strain measurement — called longitudinal apical strain — was the best predictor of the stroke-volume increase. “Longitudinal” refers to how the heart muscle lengthens and shortens along its length (top-to-bottom), and “apical” means it was measured near the tip of the heart.
What this means practically: if a vet wants to know whether pimobendan is genuinely improving a dog’s pump function, tracking this particular measurement may be more informative than relying only on simpler scan numbers. It could help vets and cardiologists pick the most useful way to monitor a dog’s response to the drug.
What This Means for Dogs on Heart Medication
A Clearer Road Map for Monitoring
If your dog is taking pimobendan for heart disease, this research matters because it improves our understanding of what the drug is actually doing — and which measurement best reflects that action. Vets who specialize in cardiology may increasingly use strain imaging to get a more detailed look at heart function in dogs on long-term medication.
This doesn’t mean your vet needs to change anything tomorrow. Most dogs on pimobendan are monitored with routine echocardiograms and check-ups. But as this kind of research builds, vets may have better tools to tell whether a dog is getting the full benefit of the drug or whether a dose adjustment might help.
Talk to Your Vet If Your Dog Takes Pimobendan
If your dog has been diagnosed with heart disease and is taking pimobendan — or if your vet has recently suggested starting the medication — it’s always reasonable to ask:
- How often should we do heart scans to check the drug is working?
- Are there any signs at home I should watch for that might mean the medication needs adjusting?
- Would a referral to a veterinary cardiologist be helpful for more detailed monitoring?
Dogs with heart disease often do well for months or years on pimobendan. Staying on top of regular check-ups is the most important thing owners can do.
Important Limitations to Keep in Mind
This was a very small pilot study — just five healthy male Beagles. The dogs did not have heart disease; they were healthy animals given a single IV dose in a research setting. Real-world dogs with heart failure, mitral valve disease, or dilated cardiomyopathy are in a very different situation, and the results here may not translate directly to them.
The findings should be seen as early, exploratory data that helps researchers and veterinary cardiologists design better, larger follow-up studies. They don’t change current treatment guidelines and don’t suggest owners should alter how their dogs take pimobendan.
The Bottom Line
A new pilot study using advanced heart scans in five awake Beagles found that pimobendan measurably increased how much blood the heart pumped per beat, and that a specific strain measurement tracked that pump boost most closely. The findings help clarify the mechanics of how this widely used heart drug works in dogs — and may eventually point vets toward better ways to monitor its effectiveness.
For dog owners, the key takeaway is straightforward: pimobendan continues to be a well-supported medication for canine heart disease, and research like this is steadily giving vets a better toolkit for managing it. Keep up with your dog’s scheduled cardiac check-ups, and don’t hesitate to ask your vet how your dog’s heart function is being tracked.
This article summarizes peer-reviewed research for educational purposes. Always consult with your veterinarian for personalized advice about your pet’s health and behavior.